Vivos Therapeutics (VVOS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.13, -8.32% vs the prior close of $0.14.
- Volume 1.62M shares, 0.1x its 50-day average (light).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
VVOS slides 8.3% to $0.13, a 52-week low. Closed at $0.13, -8.32% vs the prior close of $0.14. Day range $0.13–$0.14, opened at $0.14.
VVOS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — VVOS slides 8.3% to $0.13, a 52-week low
- Closed at $0.13, -8.32% vs the prior close of $0.14. Day range $0.13–$0.14, opened at $0.14.
- Volume was 1.62M shares, 0.1x its 50-day average of 15.63M — lighter than usual.
- Price is -34.5% vs its 50-day average ($0.20) and -84.5% vs its 200-day average ($0.85).
- 52-week range $0.13–$3.21; today's close sits at 0% of that range, 95.9% below the 52-week high.
Oct 15, 2026 — VVOS jumps 6.7% to $0.14
- Closed at $0.14, +6.72% vs the prior close of $0.13. Day range $0.13–$0.15, opened at $0.14.
- Volume was 11.52M shares, 0.7x its 50-day average of 15.55M.
- Price is -29.9% vs its 50-day average ($0.20) and -83.3% vs its 200-day average ($0.86).
- 52-week range $0.13–$3.28; today's close sits at 0% of that range, 95.6% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — VVOS slides 5.6% to $0.13, 7 down days in a row
- Closed at $0.13, -5.63% vs the prior close of $0.14. Day range $0.13–$0.14, opened at $0.14.
- Volume was 669.90K shares, 0.0x its 50-day average of 16.24M — lighter than usual.
- Price is -35.6% vs its 50-day average ($0.21) and -84.5% vs its 200-day average ($0.87).
- 52-week range $0.13–$3.28; today's close sits at 0% of that range, 95.9% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — VVOS dips 1.4% to $0.14, 6 down days in a row
- Closed at $0.14, -1.39% vs the prior close of $0.14. Day range $0.14–$0.15, opened at $0.15.
- Volume was 735.90K shares, 0.0x its 50-day average of 16.23M — lighter than usual.
- Price is -33.8% vs its 50-day average ($0.21) and -83.8% vs its 200-day average ($0.88).
- 52-week range $0.13–$3.28; today's close sits at 0% of that range, 95.7% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — VVOS slides 3.4% to $0.14, 5 down days in a row
- Closed at $0.14, -3.36% vs the prior close of $0.15. Day range $0.14–$0.15, opened at $0.15.
- Volume was 483.50K shares, 0.0x its 50-day average of 16.23M — lighter than usual.
- Price is -34.6% vs its 50-day average ($0.22) and -83.7% vs its 200-day average ($0.89).
- 52-week range $0.13–$3.28; today's close sits at 0% of that range, 95.6% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — VVOS dips 0.7% to $0.15, 4 down days in a row
- Closed at $0.15, -0.67% vs the prior close of $0.15. Day range $0.14–$0.16, opened at $0.15.
- Volume was 8.83M shares, 0.6x its 50-day average of 16.05M — lighter than usual.
- Price is -33.9% vs its 50-day average ($0.23) and -83.3% vs its 200-day average ($0.89).
- 52-week range $0.13–$3.28; today's close sits at 1% of that range, 95.5% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — VVOS dips 0.7% to $0.15, 3 down days in a row
- Closed at $0.15, -0.66% vs the prior close of $0.15. Day range $0.15–$0.15, opened at $0.15.
- Volume was 1.98M shares, 0.1x its 50-day average of 16.02M — lighter than usual.
- Price is -35.0% vs its 50-day average ($0.23) and -83.4% vs its 200-day average ($0.90).
- 52-week range $0.13–$3.28; today's close sits at 1% of that range, 95.4% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — VVOS dips 1.9% to $0.15
- Closed at $0.15, -1.95% vs the prior close of $0.15. Day range $0.14–$0.16, opened at $0.15.
- Volume was 419.00K shares, 0.0x its 50-day average of 16.01M — lighter than usual.
- Price is -36.0% vs its 50-day average ($0.24) and -83.5% vs its 200-day average ($0.91).
- 52-week range $0.13–$3.35; today's close sits at 1% of that range, 95.5% below the 52-week high.
Oct 6, 2026 — VVOS ends flat (+0.0%) to $0.15
- Closed at $0.15, +0.00% vs the prior close of $0.15. Day range $0.15–$0.16, opened at $0.15.
- Volume was 572.90K shares, 0.0x its 50-day average of 16.00M — lighter than usual.
- Price is -36.2% vs its 50-day average ($0.24) and -83.3% vs its 200-day average ($0.92).
- 52-week range $0.13–$3.42; today's close sits at 1% of that range, 95.5% below the 52-week high.
Oct 5, 2026 — VVOS rises 1.3% to $0.15, 3 up days in a row
- Closed at $0.15, +1.32% vs the prior close of $0.15. Day range $0.15–$0.16, opened at $0.15.
- Volume was 580.80K shares, 0.0x its 50-day average of 15.99M — lighter than usual.
- Price is -37.5% vs its 50-day average ($0.25) and -83.5% vs its 200-day average ($0.93).
- 52-week range $0.13–$3.42; today's close sits at 1% of that range, 95.5% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — VVOS rises 2.0% to $0.15
- Closed at $0.15, +2.01% vs the prior close of $0.15. Day range $0.15–$0.16, opened at $0.15.
- Volume was 667.40K shares, 0.0x its 50-day average of 15.99M — lighter than usual.
- Price is -39.5% vs its 50-day average ($0.25) and -83.8% vs its 200-day average ($0.94).
- 52-week range $0.13–$3.42; today's close sits at 1% of that range, 95.6% below the 52-week high.
VVOS latest news & SEC filings
Every SEC filing by or about VVOS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 4.01 — Changed its outside auditor.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Huntsman Ronald Kirk reported an other transaction of 85,910 shares at $0.58 (≈$50.00K) on Jun 30, 2026; now holds 85,910
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 3, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $5.15M (prior year $3.82M) (+34.9% vs Jun 30, 2025)
- Net income: -$5.48M (prior year -$5.01M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.31 (prior year -$0.55) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 11, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade VVOS
- Last results release: Apr 15, 2026 (8-K Item 2.02). Previous ones: Nov 19, 2025, Aug 20, 2025, May 15, 2025. Based on that rhythm, the next report is likely around Jul 15, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.33% (largest 12.7%). That is a volatile stock.
- Liquidity: about 5.74M shares (≈$752.30K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.13 vs a range of $0.13–$3.21 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Investors 3 Llc V-Co bought 308,848 shares on Mar 31, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 1, 2026; 8-K Sep 8, 2026.
- Share count: 20.12M shares outstanding (Aug 13, 2026), +168.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
VVOS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.14 | 0.14 | 0.13 | 0.13 | 1.62M |
| Oct 15, 2026 | 0.14 | 0.15 | 0.13 | 0.14 | 11.62M |
| Oct 14, 2026 | 0.14 | 0.14 | 0.13 | 0.13 | 669.90K |
| Oct 13, 2026 | 0.15 | 0.15 | 0.14 | 0.14 | 735.90K |
| Oct 12, 2026 | 0.15 | 0.15 | 0.14 | 0.14 | 483.50K |
| Oct 9, 2026 | 0.15 | 0.16 | 0.14 | 0.15 | 8.83M |
| Oct 8, 2026 | 0.15 | 0.15 | 0.15 | 0.15 | 1.98M |
| Oct 7, 2026 | 0.15 | 0.16 | 0.14 | 0.15 | 419.00K |
| Oct 6, 2026 | 0.15 | 0.16 | 0.15 | 0.15 | 572.90K |
| Oct 5, 2026 | 0.15 | 0.16 | 0.15 | 0.15 | 580.80K |
| Oct 2, 2026 | 0.15 | 0.16 | 0.15 | 0.15 | 667.40K |
| Oct 1, 2026 | 0.14 | 0.15 | 0.14 | 0.15 | 1.20M |
| Sep 30, 2026 | 0.14 | 0.15 | 0.14 | 0.15 | 2.28M |
| Sep 29, 2026 | 0.14 | 0.16 | 0.13 | 0.15 | 76.76M |
| Sep 28, 2026 | 0.14 | 0.14 | 0.13 | 0.13 | 1.45M |
| Sep 25, 2026 | 0.15 | 0.15 | 0.14 | 0.14 | 653.80K |
| Sep 24, 2026 | 0.14 | 0.15 | 0.14 | 0.15 | 928.80K |
| Sep 23, 2026 | 0.16 | 0.16 | 0.14 | 0.15 | 1.54M |
| Sep 22, 2026 | 0.16 | 0.17 | 0.15 | 0.16 | 1.10M |
| Sep 21, 2026 | 0.17 | 0.17 | 0.16 | 0.16 | 678.90K |
About Vivos Therapeutics
Vivos Therapeutics (VVOS) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in LITTLETON, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1716166.
VVOS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ronald Kirk Huntsman | Chief Executive Officer | Sep 18, 2026 |
| Gregg C Johnson | Director | Sep 18, 2026 |
| Leonard J Sokolow | Director | Sep 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bradford K. Amman | Principal Accounting Officer | Aug 26, 2026 |
| Ronald Kirk Huntsman | Chief Executive Officer | Sep 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 31, 2026 | Investors 3 Llc V-Co | Buy | 308,848 | $1.34 |
| Mar 31, 2026 | Investors 3 Llc V-Co | Buy | 1,044,777 | $1.34 |
| Mar 31, 2026 | Investors 3 Llc V-Co | Buy | 308,848 | $1.34 |
| Mar 31, 2026 | Investors 3 Llc V-Co | Buy | 1,044,777 | $1.34 |
| Mar 31, 2026 | Michael C Skaff | Buy | 308,848 | $1.34 |
| Mar 31, 2026 | Michael C Skaff | Buy | 1,044,777 | $1.34 |
| Mar 31, 2026 | Michael C Skaff | Buy | 308,848 | $1.34 |
| Mar 31, 2026 | Michael C Skaff | Buy | 1,044,777 | $1.34 |
| Mar 31, 2026 | Investors 3 Llc V-Co | Buy | 308,848 | $1.34 |
| Mar 31, 2026 | Investors 3 Llc V-Co | Buy | 1,044,777 | $1.34 |
| Mar 31, 2026 | Investors 3 Llc V-Co | Buy | 308,848 | $1.34 |
| Mar 31, 2026 | Investors 3 Llc V-Co | Buy | 1,044,777 | $1.34 |
| Mar 31, 2026 | Michael C Skaff | Buy | 308,848 | $1.34 |
| Mar 31, 2026 | Michael C Skaff | Buy | 1,044,777 | $1.34 |
| Mar 31, 2026 | Michael C Skaff | Buy | 308,848 | $1.34 |
VVOS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $17.44M | $-21.17M | -2.07 | $-15.26M |
| Dec 31, 2024 | $15.03M | $-11.14M | -2.22 | $-12.69M |
| Dec 31, 2023 | $13.80M | $-13.58M | -11.14 | $-11.95M |
| Dec 31, 2022 | $16.02M | $-23.84M | -25.90 | $-19.59M |
| Dec 31, 2021 | $16.89M | $-20.29M | — | $-15.73M |
Latest balance sheet: total assets $24.14M, total liabilities $28.13M, cash $1.77M (as of Jun 30, 2026).
VVOS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 15, 2026 | 8-K Item 2.02 (results) | $1.47 |
| Nov 19, 2025 | 8-K Item 2.02 (results) | $2.36 |
| Aug 20, 2025 | 8-K Item 2.02 (results) | $4.13 |
| May 15, 2025 | 8-K Item 2.02 (results) | $3.06 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $2.85 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $3.12 |
| Aug 15, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 29, 2024 | 8-K Item 2.02 (results) | — |
| Aug 16, 2023 | 8-K Item 2.02 (results) | — |
| Jun 8, 2023 | 8-K Item 2.02 (results) | — |
| Mar 30, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on VVOS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.